NTRK Repotrectinib Market Size and Forecast Repotrectinib, a next-generation tyrosine kinase inhibitor (TKI), is specifically designed to treat solid tumors driven by NTRK, ROS1, or ALK gene fusions. The global market for…
Category: Pharmaceutical
PTSD Prazosin Market: Size, Forecast, Drivers, and Key Trends
PTSD Prazosin Market Size and Forecast Prazosin, an off-label alpha-1 adrenergic antagonist, is primarily used to manage Post-Traumatic Stress Disorder (PTSD) related nightmares and sleep disturbances. While it is not FDA-approved for…
Sjog Ianalumab Market: Size, Forecast, Drivers, and Key Trends
Ianalumab for Sjögren’s Market Size and Forecast Ianalumab (VAY736), developed by Novartis, is an emerging biologic therapy targeting B-cell activating factor (BAFF) receptors, intended for the treatment of Sjögren’s disease (SjD). As…
Clust Sumatriptan NS Market: Size, Forecast, Drivers, and Key Trends
Sumatriptan NS Market Size and Forecast The Sumatriptan Nasal Spray (NS) market is a key component of the overall Cluster Headache and acute migraine treatment landscape. Sumatriptan is a standard therapy, valued…
RET Vandetanib Off Market: Size, Forecast, Drivers, and Key Trends
RET Vandetanib Off-Patent Market Size and Historical Context Vandetanib (Caprelsa), a multi-kinase inhibitor targeting RET, EGFR, and VEGFR, holds a historical position in treating progressive, symptomatic medullary thyroid cancer (MTC). As an…
AD Semaglutide Trials Market: Size, Forecast, Drivers, and Key Trends
AD Semaglutide Trials Market Size and Forecast The market specifically for Semaglutide in Alzheimer’s Disease (AD) trials remains purely speculative, as Novo Nordisk’s Phase 3 EVOKE and EVOKE+ studies did not meet…
Behc Thalidomide Market: Size, Forecast, Drivers, and Key Trends
Behcet’s Thalidomide Market Size and Forecast The market specifically for Thalidomide in treating Behçet’s Syndrome (BS) is nested within the broader BS therapeutic landscape, which was valued at approximately USD 105.1 Million…
CM Rimegepant ODT Market: Size, Forecast, Drivers, and Key Trends
Rimegepant ODT Market Size and Forecast Rimegepant ODT, commercialized as Nurtec ODT, is a prominent calcitonin gene-related peptide (CGRP) receptor antagonist approved for both the acute and preventive treatment of migraine. The…
RA Vobarilizumab Market: Size, Forecast, Drivers, and Key Trends
RA Vobarilizumab Market Size and Forecast Vobarilizumab is an investigational anti-interleukin-6 receptor nanobody intended for the treatment of moderate to severe rheumatoid arthritis (RA). Since it is not yet approved or marketed,…
PD Safinamide Market: Size, Forecast, Drivers, and Key Trends
PD Safinamide Market Size and Forecast Safinamide, a selective MAO-B inhibitor used as an adjunctive treatment for Parkinson’s disease (PD) patients experiencing “off” episodes, is a niche segment within the broader PD…